First-in-class targeted agent for severe alopecia areata: baricitinib

doi:10.3969/j.issn.1672-3384.2022.12.011

PDF(380 KB)

Clinical Medication Journal ›› 2022, Vol. 20 ›› Issue (12) : 56-59. DOI: 10.3969/j.issn.1672-3384.2022.12.011

Comment of New Drug

First-in-class targeted agent for severe alopecia areata: baricitinib

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 20(12): 56-59 https://doi.org/10.3969/j.issn.1672-3384.2022.12.011

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(380 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2022-09-08	2022-12-29
Issue Date
2022-12-29

Please choose a citation manager

Content to export